As rumors of rescheduling grow more prominent, concerns about big pharma’s potential control over the industry are escalating. We invited Dr. Matt Moore back for a third time to shed light on the challenges and opportunities in the development and research of cannabinoid and psychedelic drugs.
For those unfamiliar with Dr. Moore, he is an accomplished scientist with extensive experience in the pharmaceutical, cannabis, and psychedelic industries, adept at managing projects from pre-clinical stages to post-approval.”
This week, we sit down with Dr. Matthew Moore to discuss.
Does Big Pharma benefit from a rescheduling of Cannabis?
Cannabinoid Clinical Trials, challenges, and opportunities
As Arthur C. Clarke famously said, ‘The only way to discover the limits of the possible is to go beyond them into the impossible.’ And that’s exactly what Tony Verzura, the pioneering founder of Blue River Terps, is doing with cannabis innovation. With his visionary spirit, Tony is challenging the boundaries of what’s possible in cannabis, unlocking the untapped potential of terpenes.
Tony’s journey began with a simple question:
Can we harness the power of terpenes in new and innovative ways?
Can I make terpenes water soluble?
Can I turn terpenes into powder?
This week, we sit down with Tony Verzura, Founder of Blue River Terps, to discuss
How does a Cocktail whisper apply his mixologist’s skills to cannabis beverages?
He was kicked out of his family home, Rikers Island, to write best-selling books to the inspiration behind Klaus.
This week, we sit down with Warren Bobrow to discuss the following.
Inspiration behind Klaus
Wine regions & Cannabis regions
About Warren Bobrow:
Warren Bobrow is a mixologist, chef, and writer known as the Cocktail Whisperer. Bobrow is a freelance mixologist specializing in Craft Spirits. He has developed bar programs and implemented their cocktail and ice programs.
How do substances affect behavior, and how can we affect positive behavior change?
If YOU want to quit a substance, can these compounds them?
How do we give them the tools that make them more successful?
This week, we sit down with Dr. Matthew Johnson to discuss the following:
Micro, Recreational & Heroic Dose: How to think about them
Is Micro-dosing just a placebo effect
Addiction, Depression, Mental Health, and Other Opportunities
A Must Listen to Rapid Fire
About Dr. Matthew Johnson
Dr. Matthew W. Johnson, Ph.D., is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. He is one of the world’s most published scientists on the human effects of psychedelics, and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson earned his Ph.D. in experimental psychology at the University of Vermont in 2004.
Most fail to realize how simple steps can be a difference-maker.
Do new cannabis markets set themselves up for failure?
Are eager entrepreneurs trying to reinvent the wheel?
This week we sit down with Lulu Tsui to discuss:
Relationship Management/ Due Diligence
How to learn from other markets
West Coast vs EAST
About On The Revel
REVEL IS… – Opening hearts and minds to the business opportunities in legal cannabis. – Celebrating the diverse voices that are defining the next generation practices and standards for the cannabis industry. – Building towards a cannabis industry that is equitable, inclusive, and provides opportunities for all. – Choosing inspiration and collaboration for a stronger industry and a healthier business community.